Stockreport

Ocugen: Maintaining 'Buy' Rating On Positive OCU410ST Regulatory Developments [Seeking Alpha]

Ocugen, Inc.  (OCGN) 
PDF FDA and EMA regulatory alignment enables a single U.S. trial to support both BLA and MAA filings for OCU410ST, expediting potential approvals. Interim data from GARDi [Read more]